Mohamad A Mikati Selected Research

Landau-Kleffner Syndrome

3/2016	Response to immunotherapy in a patient with Landau-Kleffner syndrome and GRIN2A mutation.
4/2002	Efficacy of intravenous immunoglobulin in Landau-Kleffner syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohamad A Mikati Research Topics

Disease

28	Seizures (Absence Seizure) 05/2022 - 04/2002
19	Epilepsy (Aura) 01/2022 - 05/2006
19	Status Epilepticus (Complex Partial Status Epilepticus) 12/2021 - 03/2003
7	Alternating hemiplegia of childhood 05/2022 - 05/2014
7	Infantile Spasms (West Syndrome) 01/2017 - 03/2002
4	Dystonia (Limb Dystonia) 05/2022 - 01/2009
4	Brain Diseases (Brain Disorder) 01/2021 - 01/2016
4	Hypoxia (Hypoxemia) 10/2013 - 01/2007
3	Nervous System Diseases (Neurological Disorders) 01/2022 - 05/2020
3	Lennox Gastaut Syndrome 01/2021 - 02/2011
3	Drug Resistant Epilepsy 01/2019 - 01/2014
3	Stroke (Strokes) 01/2018 - 11/2010
3	Epileptic Syndromes 01/2017 - 09/2006
2	Cerebral Palsy (Spastic Diplegia) 12/2022 - 01/2015
2	Ventricular Fibrillation 05/2022 - 01/2021
2	Bradycardia 05/2022 - 01/2021
2	Atrophy 02/2022 - 05/2020
2	Hemiplegia (Spastic Hemiplegia) 01/2021 - 01/2015
2	Movement Disorders (Movement Disorder) 10/2020 - 03/2011
2	Tuberous Sclerosis (Bourneville's Disease) 01/2018 - 03/2002
2	Partial Epilepsies (Epilepsy, Partial) 01/2017 - 05/2011
2	Landau-Kleffner Syndrome 03/2016 - 04/2002
2	Myoclonic Epilepsies (Myoclonic Encephalopathy) 06/2015 - 09/2013
2	Dystonia 12 05/2014 - 09/2012
2	Ataxia (Dyssynergia) 01/2013 - 01/2009
2	Encephalitis (Encephalitis, Rasmussen) 01/2013 - 12/2011
2	Biotinidase Deficiency (Multiple Carboxylase Deficiency, Late Onset) 01/2013 - 11/2006
2	Ischemic Stroke 01/2013 - 09/2011
2	Idiopathic Generalized Epilepsy 08/2012 - 01/2005
1	Apnea 05/2022
1	Focal cortical dysplasia of Taylor 01/2022
1	Focal Cortical Dysplasia 01/2022
1	Hyperekplexia 11/2021
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2021
1	Muscle Spasticity (Spastic) 01/2021
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 11/2020
1	Infections 10/2020
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2020
1	Dopa-responsive Dystonia 01/2020
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019
1	Hypotension (Low Blood Pressure) 01/2018
1	Glut1 Deficiency Syndrome 01/2018
1	Hallucinations (Hallucination) 01/2018
1	Episodic Ataxia 01/2018

Drug/Important Bio-Agent (IBA)

12	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019 - 09/2003
11	Pharmaceutical PreparationsIBA 02/2022 - 03/2002
6	Adenosine Triphosphatases (ATPase)IBA 02/2022 - 09/2012
5	Kainic Acid (Kainate)IBA 10/2008 - 12/2004
4	BenzodiazepinesIBA 11/2021 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2010
4	Lamotrigine (Lamictal)FDA LinkGeneric 03/2011 - 03/2002
3	Quinidine (Chinidin)FDA LinkGeneric 02/2018 - 06/2015
3	Intravenous Immunoglobulins (IVIG)FDA Link 12/2011 - 04/2002
3	Topiramate (Topamax)FDA LinkGeneric 04/2011 - 03/2002
3	CeramidesIBA 10/2008 - 03/2003
2	Midazolam (Versed)FDA LinkGeneric 12/2021 - 10/2016
2	Biomarkers (Surrogate Marker)IBA 05/2020 - 03/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 09/2017
2	Flurothyl (Flurotyl)IBA 01/2015 - 10/2013
2	Immunoglobulin E (IgE)IBA 08/2012 - 01/2005
2	AntibodiesIBA 12/2011 - 06/2008
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2011 - 03/2003
2	Erythropoietin FDA Link 04/2011 - 01/2007
2	salicylhydroxamic acid (SHAM)IBA 04/2011 - 11/2010
2	Oxidoreductases (Dehydrogenase)IBA 03/2011 - 01/2007
2	Pyridoxine (Pyridoxin)FDA LinkGeneric 12/2009 - 03/2002
2	Neuroprotective AgentsIBA 01/2007 - 10/2006
2	Phenobarbital (Luminal)FDA Link 01/2005 - 12/2004
1	N-acetylaspartate (N-acetyl aspartate)IBA 02/2022
1	paxillineIBA 01/2022
1	Biological ProductsIBA 01/2022
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Glycine Receptors (Glycine Receptor)IBA 11/2021
1	Glycine Plasma Membrane Transport ProteinsIBA 11/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	Trihexyphenidyl (Artane)FDA LinkGeneric 10/2020
1	Sertraline (Zoloft)FDA LinkGeneric 10/2020
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 10/2020
1	Levodopa (L Dopa)FDA LinkGeneric 01/2020
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2018

Therapy/Procedure

29	Therapeutics 01/2022 - 03/2002
4	Vagus Nerve Stimulation 01/2019 - 03/2009
3	Time-to-Treatment 01/2021 - 01/2018
3	Ketogenic Diet 01/2018 - 03/2002
2	Aftercare (After-Treatment) 12/2022 - 09/2003
2	Injections 01/2021 - 12/2004
2	Hemispherectomy 01/2018 - 04/2011
2	Immunotherapy 03/2016 - 12/2011
1	Resuscitation 05/2022
1	Tracheostomy 05/2022
1	Anesthesia 05/2022
1	Intravenous Infusions 01/2021
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 11/2020
1	Precision Medicine 01/2019
1	Drug Therapy (Chemotherapy) 01/2019
1	Lasers (Laser) 01/2018